American Journal of Human Genetics Impact Factor, Quartile, Indexing, Ranking

American Journal of Human Genetics (AJHG) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Cell Press. The Print-ISSN of American Journal of Human Genetics is 0002-9297 and its abbreviation is Am J Hum Genet.

The latest Impact Factor of the American Journal of Human Genetics for 2026-2027 is 9.8.

The Publication fees (APC) is £4,120, €4,600, $5,150.

AJHG provides a record of research and review relating to heredity in humans and to the application of genetic principles in medicine and public policy, as well as in related areas of molecular and cell biology. Topics explored by AJHG include behavioral genetics, biochemical genetics, clinical genetics, cytogenetics, dysmorphology, gene therapy, genetic counseling, genetic epidemiology, genomics, immunogenetics, molecular genetics, neurogenetics, and population genetics.

AJHG welcomes submissions of articles and reports on timely subjects concerning all aspects of human genetics, including studies of model organisms that are of direct relevance to human genetics. Manuscripts should be written in a manner accessible to investigators representing diverse backgrounds in human genetics. Descriptions of new statistical methods of general interest to the genetics community are welcome. New methods should be compared to existing methods with the use of real data and/or simulations with parameters (e.g., haplotype frequencies, effect sizes) that are based on a real data example (e.g., marker or haplotype data from the HapMap project). All novel computer programs must be made publicly available by the time that the manuscript is published, and a URL for the website must be included in the Web Resources section of the manuscript. Letters commenting on material previously published in AJHG are also welcome.

AJHG does not publish reports of either single mutations or mutational surveys of previously identified loci unless they have unusual significance and substantial insight. Descriptions of new linkage assignments will be considered only if they are of special interest. Reports of negative data will not normally be considered.

• Journal Website
• PubMed
• Scopus
• SCImago